Latest 30 News in the Life Sciences Industry

Invitation: Sobi's Q4 and FY 2025 report

By: PR Newswire Association LLC. - 14 Jan 2026

Cereno Scientific Announces First Peer-Reviewed Publication on HDAC Inhibitor CS014: Antithrombotic Efficacy Without Bleeding Risk Supports Broad Potential in Cardiopulmonary Diseases

By: PR Newswire Association LLC. - 14 Jan 2026

DNV SUPPORTS NOUL IN IVDR CERTIFICATION FOR AI-BASED MEDICAL DIAGNOSTIC PRODUCTS

By: PR Newswire Association LLC. - 14 Jan 2026

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025

By: GlobeNewswire - 12 Jan 2026

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

By: GlobeNewswire - 12 Jan 2026

Curasight Announces Encouraging Preliminary Data from Phase 1 Trial Evaluating First-in-Class Radiopharmaceutical uTREAT in High-Grade Gliomas®

By: PR Newswire Association LLC. - 12 Jan 2026

Interlinked AB signs contracted distributor agreements across Europe, the Middle East, and North America

By: PR Newswire Association LLC. - 12 Jan 2026

Boehringer Ingelheim announces clinical collaboration with Jazz Pharmaceuticals to advance HER2-targeted therapy in breast cancer

By: GlobeNewswire - 12 Jan 2026

Galecto Highlights Key Strategic Priorities and Anticipated 2026 Milestones

By: GlobeNewswire - 12 Jan 2026

Annexon Accelerating Next Generation Targeted Immunotherapy Platform for Treatment of Neuroinflammatory Diseases with Multiple Registrational Milestones in 2026

By: GlobeNewswire - 12 Jan 2026

EQT Life Sciences to exit Vivasure Medical via sale to Haemonetics

By: PR Newswire Association LLC. - 12 Jan 2026

SciBase publishes information document regarding rights issue

By: PR Newswire Association LLC. - 09 Jan 2026

No serious adverse events to date in ongoing phase 1/2a clinical study of SYN321

By: PR Newswire Association LLC. - 09 Jan 2026

Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy

By: GlobeNewswire - 09 Jan 2026

Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly

By: PR Newswire Association LLC. - 09 Jan 2026

SciBase announces outcome of the offer to repurchase outstanding warrants of series TO 2

By: PR Newswire Association LLC. - 09 Jan 2026

SS Innovations Appoints Milan Rao as Global Chief Operating Officer and Chief Financial Officer

By: GlobeNewswire - 08 Jan 2026

Week 52 COACH Trial Topline Results Confirm Consistent and Durable Treatment Benefits in Children with Achondroplasia (ACH)

By: GlobeNewswire - 08 Jan 2026

Antag Therapeutics demonstrates compelling potential of its novel GIPR antagonist for obesity, reporting excellent tolerability in Phase 1 and enhanced weight loss in amylin combination study

By: GlobeNewswire - 08 Jan 2026

Muna Therapeutics Awarded $1 Million Alzheimer's Association Grant to Advance Clinical Development of Novel Oral TREM2 Agonist MNA-001 for Alzheimer's

By: PR Newswire Association LLC. - 08 Jan 2026

Diagonal Therapeutics Announces Oversubscribed $125 Million Series B Financing to Advance Clinical Development of Disease-Modifying, Clustering Antibody Pipeline

By: GlobeNewswire - 08 Jan 2026

Discontinued lawsuit against Essity regarding bond loans

By: PR Newswire Association LLC. - 08 Jan 2026

Annexon Submits Tanruprubart Marketing Authorization Application to the European Medicines Agency for Guillain-Barré Syndrome

By: GlobeNewswire - 08 Jan 2026

Sigrid Raises USD 5 M to Accelerate Breakthrough Non-Systemic Metabolic Health Technology

By: PR Newswire Association LLC. - 07 Jan 2026

Sobi to advance Gamifant® (emapalumab) in interferon-gamma-driven sepsis (IDS) based on EMBRACE topline data

By: PR Newswire Association LLC. - 07 Jan 2026

Sectra begins implementation of its first digital pathology project in Japan, aiming to improve cancer diagnostics and decrease time to treatment

By: PR Newswire Association LLC. - 07 Jan 2026

Boehringer Ingelheim advances potential first-in-class IL-11 inhibitor to Phase II Clinical Research in Idiopathic Pulmonary Fibrosis

By: GlobeNewswire - 13 Jan 2026

Nu-Tek BioSciences Reinforces Global Supply Leadership with Halal Certification Renewal

By: GlobeNewswire - 13 Jan 2026

Evaxion expands AI-Immunology™ platform into autoimmune diseases

By: GlobeNewswire - 13 Jan 2026

Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference

By: GlobeNewswire - 10 Jan 2026

Looking for more life science news?

Browse Biotechgate for global news, company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

January 2026
- Biotech Showcase™
February 2026
- Biotechgate Digital Partnering February 2026
March 2026
- Zurich: 19th Annual European Life Sciences CEO Forum

See Events »

Add an Event »

Latest company news

Invitation: Sobi's Q4 and FY 2025 report
14 Jan 2026 (PR Newswire Association LLC.)

Cereno Scientific Announces First Peer-Reviewed Publication on HDAC Inhibitor CS014: Antithrombotic Efficacy Without Bleeding Risk Supports Broad Potential in Cardiopulmonary Diseases
14 Jan 2026 (PR Newswire Association LLC.)

DNV SUPPORTS NOUL IN IVDR CERTIFICATION FOR AI-BASED MEDICAL DIAGNOSTIC PRODUCTS
14 Jan 2026 (PR Newswire Association LLC.)